Products - Children and young people | Topic | NICE

Showing 14 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: In developmentRemove ‘Status: In development’ filter

Fever in under 5s: assessment and initial management
Status:
In development | In consultation
Programme:
NICE guideline
Consultation end date:
19 September 2019
Expected publication date:
7 November 2019
Fenfluramine for treating Dravet syndrome [ID1109]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
20 November 2019
Cannabidiol for adjuvant treatment of seizures associated with Lennox-Gastaut syndrome [ID1308]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
16 September 2019
Expected publication date:
18 December 2019
Babies, children and young people's experience of healthcare
Status:
In development
Programme:
NICE guideline
Expected publication date:
7 April 2021
Looked-after children and young people
Status:
In development
Programme:
NICE guideline
Expected publication date:
26 April 2021
Children and young people with disabilities & severe complex needs: integrated health & social care support & service guidance
Status:
In development
Programme:
NICE guideline
Expected publication date:
12 May 2021
Social, emotional and mental wellbeing in primary and secondary education
Status:
In development
Programme:
NICE guideline
Expected publication date:
28 May 2021
Epilepsies in children, young people and adults
Status:
In development
Programme:
NICE guideline
Expected publication date:
2 June 2021
Self-harm in over 8s: short- and long-term management and prevention of recurrence
Status:
In development
Programme:
NICE guideline
Expected publication date:
26 January 2022
Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in children
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in children and adults ID1297
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
KTE-C19 for previously treated B-precursor acute lymphoblastic leukaemia in people aged 2 to 21 ID1336
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Rivogenlecleucel for treating haematological non-malignant diseases in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1496]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
L-glutamine for preventing painful crises in sickle cell disease in people aged 5 years and over [ID1523]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC